Intra-hospital acquisition of colonization and infection by Klebsiella pneumoniae strains producing carbapenemases and carriage evolution: A longitudinal analysis in an Italian teaching hospital from January 2017 to August 2019.
Adult
Aged
Aged, 80 and over
Anti-Bacterial Agents
/ pharmacology
Bacterial Proteins
/ metabolism
Colistin
/ pharmacology
Cross Infection
/ epidemiology
Drug Resistance, Bacterial
Epidemiological Monitoring
Female
Hospitals, Teaching
Humans
Italy
/ epidemiology
Klebsiella Infections
/ epidemiology
Klebsiella pneumoniae
/ drug effects
Longitudinal Studies
Male
Middle Aged
Rectum
/ microbiology
Retrospective Studies
Tertiary Care Centers
beta-Lactamases
/ metabolism
Carbapenemase
Colistin resistance
Colonization
Evolution
Klebsiella pneumoniae
Nosocomial transmission
Journal
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
ISSN: 1878-3511
Titre abrégé: Int J Infect Dis
Pays: Canada
ID NLM: 9610933
Informations de publication
Date de publication:
Mar 2020
Mar 2020
Historique:
received:
20
11
2019
revised:
23
12
2019
accepted:
24
12
2019
pubmed:
15
1
2020
medline:
6
5
2020
entrez:
15
1
2020
Statut:
ppublish
Résumé
We present an updated picture (1/1/2017-31/08/2019) of the frequency of carbapenemase producing Klebsiella pneumoniae (CPKP) in surveillance rectal swabs (SRS) and in clinical samples (CS) of patients admitted to a tertiary level hospital, focusing on longitudinal evolution of CPKP detected in SRS and on colistin resistant strains. Retrospective longitudinal analysis. Only the first positive CPKP strain isolated from each patient was included. 638 CPKP strains were identified (471 in SRS and 167 in CS). SRS frequency increased over time in the medical department, remained high in the surgical department (SD) and decreased in the intensive care department. Most SRS-71.3%-and 49.1% of CS had nosocomial origin; about half of the SRS were identified in the SD. Regarding SRS evolution, carriage was confirmed in 39.5% of patients, no more testing in 25.5%, clinical involvement in 24.8 %, and negative result in 10.2%. Rates of colistin resistance were 20.1% in 2017, 31.2% in 2018 and 26.9% in 2019. CPKP diffusion is still an important issue despite the surveillance program. It is vital to enhance medical staff's awareness on this because most CPKP first detections in SRS occurred during hospital stay due to a nosocomial acquisition with a comparable picture over time. Colistin resistance is increasing.
Identifiants
pubmed: 31935535
pii: S1201-9712(19)30508-9
doi: 10.1016/j.ijid.2019.12.035
pii:
doi:
Substances chimiques
Anti-Bacterial Agents
0
Bacterial Proteins
0
beta-Lactamases
EC 3.5.2.6
carbapenemase
EC 3.5.2.6
Colistin
Z67X93HJG1
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
81-88Informations de copyright
Copyright © 2020 The Author(s). Published by Elsevier Ltd.. All rights reserved.